Article
Characterization of Two <i>Campylobacter jejuni</i> Strains for Use in Volunteer Experimental-Infection Studies
23 Sept 2008
Abstract excerpt
The development of vaccines against Campylobacter jejuni would be facilitated by the ability to perform phase II challenge studies. However, molecular mimicry of the lipooligosaccharide (LOS) of most C. jejuni strains with human gangliosides presents safety concerns about the development of Guillain-Barré syndrome. Clinical isolates of C. jejuni that appeared to lack genes for the synthesis of ganglioside mimics...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
